क्यूआर कोड

Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for HER2-Positive Breast Cancer

Introduction: This study aims to assess safety and effectiveness of pertuzumab in combination with trastuzumab and docetaxel in the neoadjuvant treatment (NeoT) of HER2-positive breast cancer. Methods: Two consecutive retrospective cohorts (n = 94, 2012–2015 and 2015–2017) of adult women with HER2-p...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Cláudia Vieira, Andreia Borges, Filipa F. Pereira, Pedro Antunes, Patrícia Redondo, Luís Antunes, José M. Lopes, Francisco R. Gonçalves, Marina Borges, Maria J. Bento
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Innovative Healthcare Institute 2023-01-01
श्रृंखला:Journal of Immunotherapy and Precision Oncology
विषय:
ऑनलाइन पहुंच:https://jipo.org/doi/pdf/10.36401/JIPO-22-12
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!